Mahdi Golkaram

4PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 17, 2023
Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade.

Michal Sarfaty, Mahdi Golkaram, Samuel A Funt

|Jun 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Phillip M Rappold, Lynda Vuong, Josef Leibold

|Feb 16, 2021
HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome.

Mahdi Golkaram, Michael L Salmans, Shannon Kaplan

Pageof 1